Akoya Biosciences, Inc. (AKYA)

3.8000 -0.0500 (-1.30%) At close: 04:00PM EDT

Akoya Biosciences, Inc.

100 Campus Drive
6th Floor
Marlborough, MA 01752
United States
855 896 8401
https://www.akoyabio.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full-time employees: 330

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Brian McKelligon	President, CEO & Director	1.15M	N/A	1969
Mr. John Frederick Ek	CFO, Principal Financial Officer & Principal Accounting Officer	N/A	N/A	1976
Dr. Frederic G. Pla Ph.D.	Chief Operating Officer	445.27k	N/A	1959
Priyam Shah	Senior Director of Business Development & Investor Relations Strategy	N/A	N/A	N/A
Ms. Jennifer Kamocsay	General Counsel	N/A	N/A	1971
Dr. Niro Ramachandran Ph.D.	Chief Business Officer	298.18k	N/A	1975
Dr. Pascal Bamford Ph.D.	Senior Vice President, Research & Development and Laboratory Operations	N/A	N/A	N/A
Mr. Rob C. Hart CFA, J.D.	Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope to automate image acquisition; and PhenoImager platform that enables researchers to visualize, analyze, quantify, and phenotype cells in situ, in fresh frozen or FFPE tissue sections, and tissue microarrays utilizing an automated and high-throughput workflow. It also provides PhenoCycler and PhenoImager reagents; and biopharma services. In addition, the company offers analysis software partnerships ecosystem; inForm Tissue, an automated image analysis software package for accurately visualizing and quantifying biomarkers in tissue sections; Phenoptr, which provides functions that consolidate and analyze output tables created by inForm software; and phenoptrReports, a software that generates shareable reports and visualizations based on the phenoptr output in an intuitive front-end GUI. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts.

Corporate governance

Akoya Biosciences, Inc.’s ISS governance QualityScore as of 1 April 2024 is 9. The pillar scores are Audit: 5; Board: 10; Shareholder rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.